
Bitoz TZ 250mg/31.25mg Injection
Marketer
Osvel Pharma
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Bitoz TZ 250mg/31.25mg Injection
Tazobactam and Amoxicillin Injection (250mg/31.25mg) is a dual-action antibiotic. This medication combats bacterial infections by inhibiting microbial growth and proliferation. Administration must be under a doctor's guidance; strict adherence to the prescribed dosage and schedule is vital. Completing the full course of treatment is crucial, even with symptom improvement, as premature cessation might compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, respiratory distress) require emergency care. Inform your physician of all current medications, including over-the-counter drugs. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and hydration support recovery. Monitoring may involve diagnostic testing to assess treatment response.
Uses of Bitoz TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Bitoz TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Bitoz TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Bitoz TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Bitoz TZ 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Bitoz TZ 250mg/31.25mg Injection, offer a targeted antibacterial approach. Ceftriaxone's antibiotic action disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
The concomitant use of Bitoz TZ 250mg/31.25mg Injection and alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Bitoz TZ (250mg/31.25mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human studies remain scarce.
Breast feedingCAUTION
Administering Bitoz TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Bitoz TZ 250mg/31.25mg Injection may cause drowsiness, blurred vision, and dizziness. Refrain from operating vehicles if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Bitoz TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Bitoz TZ 250mg/31.25mg requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Bitoz TZ 250mg/31.25mg Injection is not suggested for those with mild or moderately compromised liver function.
What if you forget to take Bitoz TZ 250mg/31.25mg Injection :
Should you inadvertently omit a scheduled dose of Bitoz TZ 250mg/31.25mg Injection, seek medical advice immediately.
Facts to Know About Bitoz TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
